Akshaya Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 01-06-2024
- Paid Up Capital ₹ 0.10 M
as on 01-06-2024
- Company Age 14 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 41.85%
(FY 2017)
- Profit 67.58%
(FY 2017)
- Ebitda 417.12%
(FY 2017)
- Net Worth 40.11%
(FY 2017)
- Total Assets 35.88%
(FY 2017)
About Akshaya Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Venkateswara Jagatha and Sri Tummala serve as directors at the Company.
- CIN/LLPIN
U24232TG2010PTC070786
- Company No.
070786
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Oct 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Akshaya Laboratories Private Limited offer?
Akshaya Laboratories Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Laxatives, Essential & Aromatic Oils, Carrier Oil, Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Industrial Chemicals & Supplies, Aldehydes, Flavours & Aromatics, Aroma Flavour.
Who are the key members and board of directors at Akshaya Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sri Tummala  | Director | 11-Oct-2010 | Current |
| Venkateswara Jagatha | Director | 05-Jan-2018 | Current |
Financial Performance and Corporate Structure Insights of Akshaya Laboratories.
Akshaya Laboratories Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 41.85% increase. The company also saw a substantial improvement in profitability, with a 67.58% increase in profit. The company's net worth Soared by an impressive increase of 40.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Akshaya Laboratories?
In 2017, Akshaya Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Akshaya Laboratories?
Unlock and access historical data on people associated with Akshaya Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Akshaya Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akshaya Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
